1. Home
  2. ANY vs BOLT Comparison

ANY vs BOLT Comparison

Compare ANY & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sphere 3D Corp.

ANY

Sphere 3D Corp.

HOLD

Current Price

$1.46

Market Cap

10.0M

Sector

Finance

ML Signal

HOLD

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

N/A

Current Price

$4.87

Market Cap

10.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANY
BOLT
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
10.5M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ANY
BOLT
Price
$1.46
$4.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$30.00
$34.00
AVG Volume (30 Days)
95.9K
20.1K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,181,000.00
$7,695,000.00
Revenue This Year
$15.62
N/A
Revenue Next Year
N/A
$133.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.07
52 Week Low
$0.16
$0.26
52 Week High
$1.94
$7.35

Technical Indicators

Market Signals
Indicator
ANY
BOLT
Relative Strength Index (RSI) 52.18 50.46
Support Level $1.27 $4.27
Resistance Level $1.67 $5.22
Average True Range (ATR) 0.12 0.47
MACD -0.01 0.03
Stochastic Oscillator 37.91 22.58

Price Performance

Historical Comparison
ANY
BOLT

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: